Invention Grant
- Patent Title: Bifunctional prodrugs
-
Application No.: US15771430Application Date: 2016-10-28
-
Publication No.: US11622958B2Publication Date: 2023-04-11
- Inventor: Lutz F. Tietze , Kamala Penchalaiah
- Applicant: GEORG-AUGUST-UNIVERSITÄT GÖTTINGEN STIFTUNG ÖFFENTLICHEN RECHTS
- Applicant Address: DE Göttingen
- Assignee: GEORG-AUGUST-UNIVERSITÄT GÖTTINGEN STIFTUNG ÖFFENTLICHEN RECHTS
- Current Assignee: GEORG-AUGUST-UNIVERSITÄT GÖTTINGEN STIFTUNG ÖFFENTLICHEN RECHTS
- Current Assignee Address: DE Göttingen
- Agency: WCF IP
- Priority: DE102015118490.7 20151029,DE102016101875.9 20160203,DE102016105449.6 20160323
- International Application: PCT/EP2016/076063 WO 20161028
- International Announcement: WO2017/072295 WO 20170504
- Main IPC: A61K31/403
- IPC: A61K31/403 ; A61P35/00 ; A61K31/404 ; A61K47/68 ; C07H17/02 ; C07D209/60 ; A61K39/395
Abstract:
A first aspect of the invention relates to novel compounds and more precisely to novel bifunctional prodrugs and drugs. An additional aspect of the invention relates to antibody compound conjugates, wherein the compound is a claimed compound, and to pharmaceutical compositions containing the compound or antibody compound conjugate. The invention lastly relates to the use of this compound or antibody compound conjugates according to the invention in order to treat tumour diseases, particularly in mammals.
Public/Granted literature
- US20180311212A1 BIFUNCTIONAL PRODRUGS Public/Granted day:2018-11-01
Information query
